Evidence map›Paper›PMID 18350379›Full record

ArticleCellular and molecular neurobiology2008

Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.

Jing Wang, Xiujie Wang, Shu Jiang, Ping Lin, Jie Zhang, Yaying Wu, Zhujuan Xiong, Jing Jing Ren, Hongliang Yang

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jing WangState Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, No. 1 Keyuan 4 Road, Gaopeng Street, High-Technological Development Zone, Chengdu, Sichuan 610041, P.R. China.
Xiujie Wang
Shu Jiang
Ping Lin
Jie Zhang
Yaying Wu
Zhujuan Xiong
Jing Jing Ren
Hongliang Yang
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To provide suitable models for human GBM cancer stem cells in vitro and in vivo, and investigate their biological characteristics, a new human GBM cancer stem-like cell line, WJ2, was established in this experiment through serial passages from adherent monolayer culture to nonadherent tumor sphere culture in turns; Its partial biological characteristics were studied through cell proliferation and tumor sphere assay; cell cycle distribution, side population, and CD133 phenotype were analyzed with FCM. The expressions of CD133, Nestin, and GFAP of cancer stem-like cells and xenograft tumor cells were detected with RT-PCR and immunohistochemistry. Biological characterization, side population, CD133 phenotype and CD133 Nestin, BCRP-1, Wnt-1 gene expression revealed the stemness of this cancer stem-like cell line. Tumorigenicity heterotransplanted in nude mice; histopathological characteristics of xenograft tumor, and expressions of CD133, Nestin, and GFAP of xenograft tumor cells indicated that xenograft tumors recapitulated the phenotype and biological characterization of human primary GBM. All findings of this experimental study suggested that WJ(2) cancer stem-like cell line could accurately mimic human GBM cancer stem cell in vitro and in vivo; it would be useful in the cellular and molecular studies as well as in testing novel therapies of CSC-based anti-cancer therapies for human GBM.

Indexed as

Cell ProliferationAC133 AntigenAnimalsAntigens, CDATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 2Biomarkers, TumorBrain NeoplasmsCarcinogenicity TestsCell Culture TechniquesDrug Screening Assays, AntitumorGene Expression Regulation, NeoplasticGlial Fibrillary Acidic ProteinGlioblastomaGlycoproteinsHumansABCG2 protein, humanAC133 AntigenAntigens, CDATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 2Biomarkers, TumorGlial Fibrillary Acidic ProteinGlycoproteinsIntermediate Filament ProteinsNeoplasm ProteinsNerve Tissue ProteinsNES protein, humanNes protein, mouseNestinPeptidesPROM1 protein, humanProm1 protein, mouseRNA, MessengerWnt1 Protein

Identifiers

PMID18350379
PMCPMC11515052
OpenAlexW2088185426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.